12 / 25
1st Line (29)
N (%)
2nd Line (12)
N (%)
3rd Line (6)
N (%)
Gender
Male
19 (65%)
7 (58%)
4 (67%)
RAS mt
KRAS 12
KRAS 13
KRAS (other)
NRAS 12
NRAS 13
NRAS(other)
16 (55%)
6 (21%)
3 (10%)
1 (4%)
0
3(10%)
7 (58%)
3 (25%)
1 (8%)
0
0
1 (8%)
2 (33%)
2 (33%)
2 (33%)
0
0
0
M. Site of M1
1
2
3+
10 (35%)
16 (55%)
3 (10%)
1 (8%)
7 (58%)
4 (33%)
2 (33%)
1 (17%)
3 (50%)
Primary Site
right
left
rectum
9 (31%)
12 (41%)
8 (28%)
5 (42%)
0
7 (58%)
3 (50%)
1 (17%)
2 (33%)
Treatment
Folfox
Folfiri
Antiangiogenics
Other
26 (86%)
1 (4%)
9 (31%)
3 (10%)
3 (25%)
7 (58%)
5 (42%)
2 (17%)
1 (17%)
0
0
5 (83%)
Patient characteristics